ArticleThe Journal of biological chemistry2026
CEP55 promotes prostate cancer progression via TPX2-dependent activation of AURKA-PI3K-AKT signaling and inhibition of ferroptosis.
Lizhe Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.